Update
Charlotte Vermehren joined LiPlasome as DMPK... Dr. Madsen has more than 20 years experience within drug discovery and cancer research...
The upcoming biotech company LiPlasome Pharma A/S is launching a new visual identity... LiPlasome Pharma has successfully concluded part of its preclinical studies and demonstrated proof of principle of the tumor activated and integrated prod... LiPlasome Pharma is represented at conventions and other scientific events around the world - all year round. Stay updated on where to find and meet LiPlasome Pharma...LiPlasome Pharma welcomes Charlotte Vermehren as DMPK Manager
August 1 2008
LiPlasome Pharma welcomes Mogens Winkel Madsen as Chief Scientific Officer
May 9 2008
Creating a successful business with a new visual identity
December 20 2007
Current Progress
December 19 2007
Meet LiPlasome
December 17 2007
